Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Ground-breaking discovery reveals common master switch for brain-related diseases

Ground-breaking discovery reveals common master switch for brain-related diseases

New fruit fly study shows the whole-body impact of Alzheimer’s disease

New fruit fly study shows the whole-body impact of Alzheimer’s disease

Study offers new clues to early detection of frontotemporal dementia in middle age

Study offers new clues to early detection of frontotemporal dementia in middle age

New drug candidate disrupts the link between herpes virus and Alzheimer’s disease

New drug candidate disrupts the link between herpes virus and Alzheimer’s disease

Targeting PME-1 may offer new strategies for treating neurological disorders and cancer

Targeting PME-1 may offer new strategies for treating neurological disorders and cancer

Disparities in access to novel infusion treatment for Alzheimer's disease revealed

Disparities in access to novel infusion treatment for Alzheimer's disease revealed

New approach directly combats the progression of Alzheimer’s and ALS

New approach directly combats the progression of Alzheimer’s and ALS

New candidate compounds show promise for Alzheimer's and pain treatment

New candidate compounds show promise for Alzheimer's and pain treatment

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

Sedentary behavior linked to increased Alzheimer's risk in older adults

Sedentary behavior linked to increased Alzheimer's risk in older adults

Mitochondrial DNA editing offers new hope for neurodegenerative disease treatment

Mitochondrial DNA editing offers new hope for neurodegenerative disease treatment

Novel Alzheimer's therapy shows low risk of severe side effects

Novel Alzheimer's therapy shows low risk of severe side effects

Breakthrough discovery offers hope for treating neurodegenerative diseases

Breakthrough discovery offers hope for treating neurodegenerative diseases

HIV drugs found to significantly reduce Alzheimer's risk in new study

HIV drugs found to significantly reduce Alzheimer's risk in new study

Study links sleep apnea to damage in brain areas critical for memory

Study links sleep apnea to damage in brain areas critical for memory

Motivation for healthy habits declines after learning Alzheimer’s risk

Motivation for healthy habits declines after learning Alzheimer’s risk

Trump policies at odds with ‘make America healthy again’ push

Trump policies at odds with ‘make America healthy again’ push

Emotional and ethical factors influence a person's decision to know Alzheimer’s risk

Emotional and ethical factors influence a person's decision to know Alzheimer’s risk

ADIS project to focus on early detection and prevention of Alzheimer's disease

ADIS project to focus on early detection and prevention of Alzheimer's disease

Boosting glucose metabolism in glial cells reduces neurodegeneration in fruit flies

Boosting glucose metabolism in glial cells reduces neurodegeneration in fruit flies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.